Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
COVID-19
Human papillomavirus (HPV)
SAGE documentation
2022
Position paper
Clear all
Type of publications
SAGE documentation
(11)
Topics
Position paper
(11)
Available to download in languages
English (EN)
(11)
Regions
Countries
Diseases
COVID-19
(10)
Human papillomavirus (HPV)
(1)
Hepatitis A
(1)
Influenza
(1)
Malaria
(1)
Mpox // Monkeypox
(2)
Vaccine topics
Target population
Methodological quality (AMSTAR 2)
Publication date
2022
(11)
2023
(2)
2021
(2)
2020
(1)
2018
(2)
2017
(1)
2015
(2)
2014
(1)
2013
(1)
2008
(1)
11 results found
2022
∙
SAGE
Human papillomavirus vaccines: WHO position paper, December 2022
2022
∙
SAGE
Interim recommendations for use of the ChAdOx1-S [recombinant] vaccine against COVID-19 (AstraZeneca COVID-19 vaccine AZD1222 Vaxzevria™, SII COVISHIELD™)
2022
∙
SAGE
Interim recommendations for use of the Moderna mRNA-1273 vaccine against COVID-19
2022
∙
SAGE
WHO interim recommendations for use of the Pfizer–BioNTech COVID-19 vaccine, BNT162b2 - 18 August 2022
2022
∙
SAGE
Interim recommendations for the use of the Janssen Ad26.COV2.S (COVID-19) vaccine
2022
∙
SAGE
Interim recommendations for use of the inactivated COVID-19 vaccine BIBP developed by China National Biotec Group (CNBG), Sinopharm
2022
∙
SAGE
Interim recommendations for use of the inactivated COVID-19 vaccine, CoronaVac, developed by Sinovac
2022
∙
SAGE
Good practice statement on the use of second booster doses for COVID-19 vaccines
2022
∙
SAGE
Interim recommendations for use of the Bharat Biotech BBV152 COVAXIN® vaccine against COVID-19
2022
∙
SAGE
Interim recommendations for use of the Valneva VLA2001 vaccine against COVID-19
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register